Forget for a while broker reports, US and ROW reported intentions re relenza, savaged BTA sp and the progress or not of the swine flu.
Only small percentages of people are willing to have vaccines.
Governments are committed to antivirus pandemic supplies and therefore they only have one reasonable choice, and it isn't tamiflu! When finally it is no longer relenza, it will be lani, and when lani is out of favour, it might be flunet.
GSK will make hay while the relenza sun shines. While it shines on them, it shines on BTA.
Simple.
BTA Price at posting:
$2.01 Sentiment: Hold Disclosure: Held
